JAN (NYSE:JAN – Get Free Report) was downgraded by equities research analysts at Zacks Research from a “strong-buy” rating to a “hold” rating in a research report issued on Tuesday, Zacks reports.
JAN has been the topic of several other reports. Royal Bank Of Canada upped their price objective on shares of JAN from $30.00 to $34.00 and gave the stock an “outperform” rating in a report on Monday, August 10th. Huntington initiated coverage on shares of JAN in a research report on Thursday, September 10th. They set an “outperform” rating and a $36.00 price objective for the company. JPMorgan Chase & Co. lifted their target price on shares of JAN from $30.00 to $34.00 and gave the company an “overweight” rating in a report on Tuesday, August 18th. Scotiabank boosted their target price on JAN from $31.00 to $33.00 and gave the company a “sector outperform” rating in a research report on Thursday, September 17th. Finally, Wells Fargo & Company cut their target price on JAN from $35.00 to $34.00 and set an “overweight” rating on the stock in a research report on Monday. One research analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $32.31.
Check Out Our Latest Stock Analysis on JAN
JAN Stock Down 3.1%
NYSE JAN opened at $28.32 on Tuesday. The firm’s 50-day moving average is $30.00 and its two-hundred day moving average is $28.27. JAN has a 12 month low of $22.76 and a 12 month high of $32.83.
JAN (NYSE:JAN – Get Free Report) last announced its earnings results on Tuesday, August 4th. The company reported $0.05 earnings per share for the quarter, missing the consensus estimate of $0.23 by ($0.18). The business had revenue of $216.46 million for the quarter, compared to the consensus estimate of $203.32 million. The firm’s revenue for the quarter was up 45.4% on a year-over-year basis. JAN has set its FY 2026 guidance at 0.950-0.980 EPS. On average, equities analysts anticipate that JAN will post 0.97 EPS for the current year.
Hedge Funds Weigh In On JAN
Several institutional investors have recently bought and sold shares of the company. Nisa Investment Advisors LLC acquired a new stake in shares of JAN during the third quarter worth about $27,000. Sumitomo Mitsui DS Asset Management Company Ltd purchased a new position in shares of JAN in the third quarter valued at approximately $627,000. State of Alaska Department of Revenue boosted its stake in shares of JAN by 57.6% in the third quarter. State of Alaska Department of Revenue now owns 36,557 shares of the company’s stock valued at $1,082,000 after purchasing an additional 13,367 shares during the period. WINTON GROUP Ltd acquired a new position in shares of JAN in the second quarter valued at approximately $2,985,000. Finally, Engineers Gate Manager LP acquired a new position in shares of JAN in the second quarter valued at approximately $15,274,000. 6.27% of the stock is owned by institutional investors and hedge funds.
More JAN News
Here are the key news stories impacting JAN this week:
- Neutral Sentiment: The most relevant available fundamental backdrop remains JAN’s latest quarterly report: earnings of $0.05 per share missed the $0.23 analyst consensus, although revenue of $216.46 million exceeded estimates and increased 45.4% year over year. Management maintained fiscal 2026 EPS guidance of $0.95 to $0.98, which may provide some support but does not eliminate concerns about profitability and the earnings shortfall.
About JAN
JanOne Inc (NYSE: JAN) is a social-impact and technology company focused on addressing the opioid crisis. Its activities have included the development and commercialization of solutions intended to support opioid-related treatment and prevention, with an emphasis on using business and technology to promote measurable social benefits.
Through its subsidiaries and related operations, JanOne has also pursued financial technology initiatives, including blockchain-based payment and transaction solutions.
Read More
- Five stocks we like better than JAN
- GM Beat and Added a $20 Billion Buyback—Why Did the Stock Fall?
- Intercepting Growth: Karman Secures $218M Lockheed Martin Deal
- Tech Stocks Took a Hit—These 2 Pharma Stocks Are Near New Highs
- Chip Stocks Have Pulled Back—Here’s How 3 Semiconductor ETFs Stack Up for Investors
Receive News & Ratings for JAN Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JAN and related companies with MarketBeat.com's FREE daily email newsletter.
